Travere Therapeutics Inc.

NASDAQ: TVTX · Real-Time Price · USD
18.76
0.53 (2.91%)
At close: Aug 15, 2025, 12:49 PM

Travere Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-4.27 -5.99 -4.81 -10.31
PEG Ratio
-0.02 0.09 -0.11 0.67
PS Ratio
5.89 4.60 6.32 8.16
PB Ratio
23.26 3.32 31.29 6.15
P/FCF Ratio
-4.06 -2.07 -6.24 -47.69
P/OCF Ratio
-5.79 -2.38 -7.2 -125.55
OCF/S Ratio
-1.02 -1.93 -0.88 -0.07
Debt / Equity Ratio
6.80 2.02 9.51 0.87
Quick Ratio
2.04 3.41 3.37 4.64
Current Ratio
2.08 3.47 3.42 4.70
Asset Turnover
0.39 0.18 0.32 0.29
Interest Coverage
-28.67 -33.24 -22.84 -7.09
Return on Equity
-5.44 -0.55 -6.5 -0.6
Return on Assets
-0.54 -0.14 -0.41 -0.23
Return on Invested Capital
-0.69 -0.61 -0.47 -0.21
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.97 0.92 0.96 0.97
Net Profit Margin
-1.38 -0.77 -1.31 -0.79
Pretax Profit Margin
-1.37 -2.59 -1.31 -0.79
Operating Profit Margin
-1.38 -2.59 -1.19 -0.61
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-1.14 -2.25 -1.41 -0.82